Proxi Biotech

Vaccines targeting AMR

Antimicrobial resistance (AMR) is one of the worlds most pressing medical problems. We are closing in on what is known as the post-antibiotic era where the most simple infections will result in deaths. Alternative solutions to antibiotics are needed. With a novel technology, Proxi Biotech develops vaccines targeting some of the most critical AMR infections.

Proxi Biotech Team


Kasper Gubba Ørtenblad, René Jørgensen, Aria Aminzadeh